Epidemiology of genital prolapse: observations from the Oxford Family Planning Association Study

British Journal of Obstetrics and Gynaecology
J MantM Vessey

Abstract

To explore the epidemiology of uterovaginal and post-hysterectomy prolapse. Cohort study. Seventeen large family planning clinics in England and Scotland. 17,032 women who attended family planning clinics between 1968 and 1974, aged between 25 and 39 years at study entry. Annual follow up by interview, postal or telephone questionnaire until July 1994. Further details on all hospital admissions were obtained from the hospital discharge summaries. All women were flagged at time of recruitment in the NHS central registers. In-patient admission with diagnosis of prolapse (ICD codes 8th Revision 623.0-623-9). The incidence of hospital admission with prolapse is 2.04 per 1000 person-years of risk. Age, parity, calendar period and weight were significantly associated with risk of an inpatient admission with prolapse after adjustment for principal confounding factors. Significant trends were observed with regard to smoking status and obesity (Quetelet Index) at entry to the study and risk of prolapse. Social class, oral contraceptive use and height were not significantly associated with risk of prolapse. The incidence of prolapse which required surgical correction following hysterectomy was 3.6 per 1000 person-years of risk. The cumul...Continue Reading

References

May 1, 1992·British Journal of Obstetrics and Gynaecology·M P VesseyD Yeates
Nov 1, 1991·Annals of Epidemiology·P Allard, L Rochette
Apr 1, 1991·American Journal of Obstetrics and Gynecology·S H Cruikshank
Sep 1, 1990·British Journal of Obstetrics and Gynaecology·R E AllenD W Warrell
Dec 16, 1989·BMJ : British Medical Journal·M P VesseyD Yeates
Jun 1, 1988·Baillière's Clinical Obstetrics and Gynaecology·S L Stanton
Sep 1, 1986·General Hospital Psychiatry·S L Keill
Jun 26, 1982·Lancet·Z S AL-Rawi, Z T Al-Rawi
Aug 1, 1993·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·H S Virtanen, J I Mäkinen
Feb 1, 1994·British Journal of Obstetrics and Gynaecology·C Spence-JonesC N Hudson

❮ Previous
Next ❯

Citations

Oct 20, 2001·Pharmacoepidemiology and Drug Safety
Jul 8, 2009·Diseases of the Colon and Rectum·Catherine E TurnerChristopher Benness
Mar 5, 2005·Der Urologe. Ausg. A·K P JünemannC Seif
Jan 14, 2005·International Urogynecology Journal and Pelvic Floor Dysfunction·Amy L O'BoyleGary D Davis
Sep 28, 2004·International Urogynecology Journal and Pelvic Floor Dysfunction·Kaven BaesslerBernhard Schuessler
Nov 2, 2005·International Urogynecology Journal and Pelvic Floor Dysfunction·Patrick J WoodmanJoseph I Schaffer
Dec 13, 2005·International Urogynecology Journal and Pelvic Floor Dysfunction·Boris GabrielAxel zur Hausen
Dec 21, 2005·International Urogynecology Journal and Pelvic Floor Dysfunction·Gregory S JackLarissa V Rodríguez
Apr 23, 2005·International Urogynecology Journal and Pelvic Floor Dysfunction·Boris GabrielDirk Watermann
Jun 30, 2005·International Urogynecology Journal and Pelvic Floor Dysfunction·Gunilla TegerstedtMargareta Hammarström
Sep 24, 2005·International Urogynecology Journal and Pelvic Floor Dysfunction·Steven Swift
Mar 29, 2006·International Urogynecology Journal and Pelvic Floor Dysfunction·Hung-Yen ChinKuo-Hwa Wang
Nov 23, 2006·International Urogynecology Journal and Pelvic Floor Dysfunction·Ching-Chung LiangShuenn-Dhy Chang
Oct 18, 2006·International Urogynecology Journal and Pelvic Floor Dysfunction·Daniel M MorganJohn O L DeLancey
Mar 3, 2007·International Urogynecology Journal and Pelvic Floor Dysfunction·I Diez-ItzaA Becerro
Feb 6, 2008·International Urogynecology Journal and Pelvic Floor Dysfunction·W Thomas GregoryJau-Shin Lou
May 28, 2008·International Urogynecology Journal and Pelvic Floor Dysfunction·Ebenezer O BabalolaJohn B Gebhart
May 31, 2008·International Urogynecology Journal and Pelvic Floor Dysfunction·S MeyerL Juillerat-Jeanneret
Aug 5, 2008·International Urogynecology Journal and Pelvic Floor Dysfunction·H P Dietz
Sep 6, 2008·International Urogynecology Journal and Pelvic Floor Dysfunction·Patrick DällenbachMichel Boulvain
Oct 16, 2008·International Urogynecology Journal and Pelvic Floor Dysfunction·M H KerkhofH A M Brölmann
Feb 14, 2009·International Urogynecology Journal and Pelvic Floor Dysfunction·F LenzC Sohn
Jun 6, 2009·International Urogynecology Journal and Pelvic Floor Dysfunction·Mou-Jong SunChin-San Liu
Apr 29, 2009·International Urogynecology Journal and Pelvic Floor Dysfunction·H P DietzP J Bedwell
Aug 6, 2009·International Urogynecology Journal and Pelvic Floor Dysfunction·Benjamin FeinerYoram Abramov
May 16, 2009·International Urogynecology Journal and Pelvic Floor Dysfunction·Marijke C Ph Slieker-ten HoveMark E Vierhout
Aug 7, 2009·International Urogynecology Journal and Pelvic Floor Dysfunction·Dharmesh S KapoorMausumi Das
Sep 17, 2009·International Urogynecology Journal·Ling-Hong TsengChyi-Long Lee
Dec 22, 2009·International Urogynecology Journal·Sebastien NovellasPatrick Chevallier
May 7, 2010·International Urogynecology Journal·M A T BortoliniM Alarab
Apr 27, 2010·International Urogynecology Journal·Mirjam WeemhoffHans P Dietz
Jun 23, 2011·International Urogynecology Journal·Irene Diez-ItzaCristina Sarasqueta
Jul 27, 2011·International Urogynecology Journal·Maria Augusta Tezelli Bortolini, Diaa E E Rizk
Aug 19, 2011·International Urogynecology Journal·Catharina ForsgrenDaniel Altman
Aug 9, 2011·International Urogynecology Journal·Mirjam WeemhoffFrans J M E Roumen
Nov 10, 2011·International Urogynecology Journal·Peter TakacsCarlos A Medina
Apr 25, 2012·International Urogynecology Journal·Turhan AranMesut A Unsal
May 16, 2012·International Urogynecology Journal·Ka Lai ShekHans Peter Dietz
Oct 22, 2013·International Urogynecology Journal·Matthew D Barber, Christopher Maher
Oct 12, 2013·Abdominal Imaging·Ana Catarina A Silva, Dean D T Maglinte
Jul 14, 2007·Archives of Gynecology and Obstetrics·Dennis H KimSherif R Aboseif
Jun 1, 2012·Archives of Gynecology and Obstetrics·M A El-NazerM A El-Etriby
Sep 4, 2012·Archives of Gynecology and Obstetrics·Umberto Leone Roberti MaggioreSimone Ferrero

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

European Journal of Obstetrics, Gynecology, and Reproductive Biology
F ChiaffarinoF Parazzini
European Journal of Obstetrics, Gynecology, and Reproductive Biology
K M Rinne, P P Kirkinen
© 2021 Meta ULC. All rights reserved